| For: | Zheng YF, Fu X, Wang XX, Sun XJ, He XD. Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients. World J Clin Cases 2021; 9(33): 10075-10087 [PMID: 34904077 DOI: 10.12998/wjcc.v9.i33.10075] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i33/10075.htm |
| Number | Citing Articles |
| 1 |
Kiera Murphy, Bansri Patel, Shantelle Griffith, Thomas N. Helm. Regorafenib‐Induced Hand‐Foot Skin Reaction in an Adolescent. Pediatric Dermatology 2025; 42(6): 1235 doi: 10.1111/pde.15967
|
| 2 |
Teja Mallela, Lily Kaufman, Brittany Dulmage. Regional limb cooling for the prevention of chemotherapy-induced toxicities: a narrative review. Supportive Care in Cancer 2025; 33(8) doi: 10.1007/s00520-025-09689-y
|
| 3 |
Chunyu Tian, Minghui Wang, Hancheng Liu, Jianping Liu, Mengze Xu, Lihui Ma. Efficacy and safety of neoadjuvant pyrotinib plus docetaxel/liposomal doxorubicin/cyclophosphamide for HER2-positive breast cancer. Irish Journal of Medical Science (1971 -) 2023; 192(3): 1041 doi: 10.1007/s11845-022-03093-9
|
| 4 |
Nadean F. Alnajjar, Ryan Chen, Mary Jane Zimarowski, Christopher Iriarte. Toxic Erythema of Chemotherapy: Updates in Evaluation and Management. Current Dermatology Reports 2025; 14(1) doi: 10.1007/s13671-025-00471-1
|
| 5 |
Katsuhiko Nara, Ayumi Taguchi, Takehito Yamamoto, Tetsushi Tsuruga, Yuri Tojima, Yuichiro Miyamoto, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Tappei Takada, Hiroshi Suzuki, Yutaka Osuga. Efficacy of regional cooling + oral dexamethasone for primary prevention of hand-foot syndrome associated with pegylated liposomal doxorubicin. Supportive Care in Cancer 2023; 31(5) doi: 10.1007/s00520-023-07718-2
|
| 6 |
Ling-Ming Tseng, Fang Ming Chen, Shou-Tung Chen, Fiona Tsui-Fen Cheng, Tsu-Yi Chao, Ming-Shen Dai, Woei-Yau Kao, Ming-Hsin Yeh, Dar-Ren Chen, Liang-Chih Liu, Hewi Chung Wang, Hong-Tai Chang, Being Whey Wang, Jyh-Cherng Yu, Shin Cheh Chen, Guo-Shiou Liao, Ming-Feng Hou. Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer: A Prospective, Randomized, Multicenter, Phase II Study. Oncology Research and Treatment 2024; 47(10): 484 doi: 10.1159/000540369
|
| 7 |
Ralph F. Mangusan, Irene Ekwede, Anaida Widell. CE: HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era. AJN, American Journal of Nursing 2022; 122(12): 32 doi: 10.1097/01.NAJ.0000901848.07128.92
|
| 8 |
Sanja Brnić, Bruno Špiljak, Lucija Zanze, Ema Barac, Robert Likić, Liborija Lugović-Mihić. Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review. Biomedicines 2025; 13(8): 1901 doi: 10.3390/biomedicines13081901
|
| 9 |
Yohei Iimura, Hirotoshi Iihara, Yoshitaka Saito, Hisanaga Nomura, Takuya Iwamoto, Mayumi Kotera, Yusuke Tsuchiya, Tatsuya Sumiya, Mariko Kono, Daisuke Hirate, Tomohiro Kurokawa, Toshinobu Hayashi, Hironobu Hashimoto, Junichi Higuchi, Ryuta Urakawa, Hiroyuki Saotome, Seiichiro Kuroda. Chemotherapy-related hand–foot syndrome and hand–foot skin reaction: a review of management and possible approaches for Asian patients by the Japanese pharmacist-led oncodermatology study team. International Journal of Clinical Oncology 2025; 30(12): 2474 doi: 10.1007/s10147-025-02895-y
|
| 10 |
Rahul Ladwa, Gerald Fogarty, Peggy Chen, Gurpreet Grewal, Chris McCormack, Victoria Mar, Delphine Kerob, Kiarash Khosrotehrani. Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective. Cancers 2024; 16(14): 2526 doi: 10.3390/cancers16142526
|
